Clinical trials
Carcinoma, Ovarian Epithelial trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 2 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Terminated | 5 |
| Active, not recruiting | 4 |
| Recruiting | 3 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 6 |
| ImmunoGen, Inc. | 3 |
| Medical University of Vienna | 3 |
| Amgen | 2 |
| AstraZeneca | 2 |
| AbbVie | 1 |
| Bristol-Myers Squibb | 1 |
| CanariaBio Inc. | 1 |
| Daiichi Sankyo | 1 |
| EBMT Solid Tumors Working Party | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Ovarian Epithelial | 36 |
| Ovarian Neoplasms | 20 |
| Fallopian Tube Neoplasms | 18 |
| Neoplasms | 7 |
| Breast Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Squamous Cell Carcinoma of Head and Neck | 3 |
| Triple Negative Breast Neoplasms | 3 |
| Blast Crisis | 2 |
| Burkitt Lymphoma | 2 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.